Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

Also called NCT03547336

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 212 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03547336
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03547336. Randomized; no masking; primary purpose treatment. Start 2018-06-29 (actual); primary completion 2020-01-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration
Condition
End Stage Renal Disease
Intervention (Device)
Theranova 400 Dialyzer
Intervention (Device)
FX800 Dialyzer
Lead sponsor
Vantive Health LLC (class: industry)
Collaborator
Baxter Healthcare Corporation (class: industry)

Record details

Record id
cardio:ct-nct03547336
Content hash
b49aaddb1370c9311f217107171403433351c860d7621cbdf0f26badef25efe2